SOTHEMA Act. Provenant de Regroupement SOT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 27.64
- Price/Sales
- 2.92
- Dividend Yield (Trailing)
- 2.48%
- Dividend Yield (Forward)
- 2.48%
- Total Yield
- 2.48%
Company Profile
SOTHEMA engages in representation, purchase and sale of pharmaceutical, chemical, health-related, biological, veterinary, plant-based, cosmetic and scented products. The company sells its products in Morocco and overseas.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- http://www.sothema.com
Comparables
Valuation
|
Metric
|
SOT
|
SBM
|
RIS
|
|---|---|---|---|
Price/Earnings (Normalized) | 27.64 | — | 31.44 |
Price/Book Value | 4.84 | — | 2.45 |
Price/Sales | 2.92 | — | 3.09 |
Price/Cash Flow | 24.40 | — | 10.35 |
Price/Earnings
SOT
SBM
RIS
Financial Strength
|
Metric
|
SOT
|
SBM
|
RIS
|
|---|---|---|---|
Quick Ratio | 1.02 | 1.66 | 1.04 |
Current Ratio | 1.87 | 2.11 | 1.05 |
Interest Coverage | 20.05 | — | 3.51 |
Quick Ratio
SOT
SBM
RIS
Profitability
|
Metric
|
SOT
|
SBM
|
RIS
|
|---|---|---|---|
Return on Assets (Normalized) | 11.93% | 18.26% | 3.02% |
Return on Equity (Normalized) | 22.19% | 31.36% | 9.39% |
Return on Invested Capital (Normalized) | 17.52% | 20.24% | 11.65% |
Return on Assets
SOT
SBM
RIS
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Gqwnbwxc | Fhkp | $733.3 Bil | |
JNJ
| Johnson & Johnson | Dhpnngym | Sccws | $360.8 Bil | |
MRK
| Merck & Co Inc | Bqtmwgdlk | Ghl | $329.8 Bil | |
ABBV
| AbbVie Inc | Lnwtqfy | Ylh | $283.3 Bil | |
AZN
| AstraZeneca PLC ADR | Nmzqkscqz | Zvvy | $237.7 Bil | |
NVS
| Novartis AG ADR | Hbnmcydqg | Jkbt | $203.4 Bil | |
RHHBY
| Roche Holding AG ADR | Tvsvhfjpk | Fkvg | $197.6 Bil | |
AMGN
| Amgen Inc | Xjqzxffgk | Zxcf | $166.4 Bil | |
PFE
| Pfizer Inc | Hynyvhs | Tjj | $159.7 Bil | |
SNY
| Sanofi SA ADR | Hfwyydypf | Ctmk | $125.1 Bil |